Tetra Bio-Pharma
$0.000200
19
-$0.00-83.74% Friday 19:28
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
86,227.77
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
16OctExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.02
-0.02
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0064
Financials
-Profit Margin
Unprofitable0Revenue
-41.31MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Precious Metals
Pharmaceuticals: Other
Health Technology
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.
Show more...
CEO
Dr. Guy Chamberland M.Sc., Master Herbal
Employees
33
Country
Canada
ISIN
CA88166Y1007
WKN
000A2ASQ8
Listings
0 Comments
Share your thoughts
FAQ
What is Tetra Bio-Pharma stock price today?▼
The current price of TBPMF is $0.00 USD — it has decreased by -83.74% in the past 24 hours. Watch Tetra Bio-Pharma stock price performance more closely on the chart.
What is Tetra Bio-Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Tetra Bio-Pharma stocks are traded under the ticker TBPMF.
What is Tetra Bio-Pharma market cap?▼
Today Tetra Bio-Pharma has the market capitalization of 86,227.77
What were Tetra Bio-Pharma earnings last quarter?▼
TBPMF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tetra Bio-Pharma revenue for the last year?▼
Tetra Bio-Pharma revenue for the last year amounts to 0 USD.
What is Tetra Bio-Pharma net income for the last year?▼
TBPMF net income for the last year is -41.31M USD.
How many employees does Tetra Bio-Pharma have?▼
As of July 16, 2026, the company has 33 employees.
In which sector is Tetra Bio-Pharma located?▼
Tetra Bio-Pharma operates in the Health & Wellness sector.
When did Tetra Bio-Pharma complete a stock split?▼
Tetra Bio-Pharma has not had any recent stock splits.
Where is Tetra Bio-Pharma headquartered?▼
Tetra Bio-Pharma is headquartered in Orléans, Canada.